- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03140215
Comparative Study of Baska & I-gel for Ventilation of Female Patients During Minor Procedures
Comparative Study of Baska & I-Gel for Spontaneously Ventilated Females During Minor Gynecological Procedures
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Population of study & disease condition : 2 equal groups (n=30), female patients enrolled for minor gynecological procedures (D&C or hysteroscopy), All patients received general anesthesia with spontaneous ventilation using Supra-glottic airway Device (SAD). Group A (Baska) & group B ( I-gel).
Inclusion Criteria: Age: 18-55, American Society of Anesthesia (ASA) 1 or 2, BMI<35 & Low risk of aspiration.
Exclusion Criteria: Anticipated upper airway problem, Gastrointestinal tract (GIT, disease, pregnancy & High risk of aspiration.
Methodology: All patients received fentanyl 1 micro gram/Kg, Propofol(2-4mg/Kg) was titrated to induce anesthesia, followed by manual ventilation with sevoflurane (2-4%) in Oxygen.All devices were inserted by one of 2 investigators.
Data collection: 1- Demographic Data: age,weight,height.2-duration of anesthesia.3- Data related to device insertion: Time of insertion,duration of anesthesia, seal pressure,peak airway pressure, Fiberoptic (FO)view of the larynx ,vomiting or regurgitation, postoperative laryngeal spasm or blood on the device after removal.
Primary outcome: To detect seal pressure and fitting against laryngeal aperture detected by FO. Secondary outcome:To determine Peak pressure, incidence of complications: vomiting or regurgitation, blood on the device after removal (indicating trauma to the airway) or postoperative laryngeal spasm..
Statistical analysis: For analysis of continuous variables independent sample t-test will be applied and for categorical variables chi-square test will be used.value of p<0.05 will be considered significant.
Sample size:
Sample size was calculated using EpiCalc program using the following data : mean seal pressure for Baska :29.98 , mean seal pressure for I-Gel: 25.62. SD: 4.9
, study power 80% confidence interval . P value<0.05. the calculated sample size was found to be 19 for each group (overall 38), so the investigators will allocate 30 patient in each group to avoid drop out.
Statistical analysis:
Source of funding This study will be attributed to Department of Anesthesiology, Faculty of medicine, Cairo University. Support will be provided solely from departmental sources. Keywords: Baska, I-Gel, Supra-glottic airway devices, seal pressure
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female ASA1,2
- Age 18-55
- BMI<35
Exclusion Criteria:
- Anticipated upper airway problem
- GIT disease
- Pregnancy
- High risk of aspiration
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Baska Device ventilation group
Device: laryngeal mask insertion (Baska)
|
Other Names:
Other Names:
|
|
Active Comparator: I-Gel device ventilation group
Device: laryngeal mask insertion ( I-gel )
|
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
seal pressure
Time Frame: seal pressure will be assessed 3minutes after induction of general anesthesia.
|
Airway Sealing Pressure in cmH2O at 5 mins postplacement.The airway sealing pressure was the pressure at which leak starts.
This leak pressure was calculated as the plateau airway pressure reached with fresh gas flow 6 l/min, and pressure adjustment valve set at 70 cmH2O..
|
seal pressure will be assessed 3minutes after induction of general anesthesia.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fiberoptic view of the larynx.
Time Frame: Fiberoptic view will be assessed 5 minutes after induction of anesthesia.
|
The fiberoptic device will be introduced through the device to visualize & record the view
|
Fiberoptic view will be assessed 5 minutes after induction of anesthesia.
|
|
Peak airway pressure in CmH2O
Time Frame: during the operation the operation
|
The peak airway pressure will be monitored during the operation time
|
during the operation the operation
|
|
incidence of vomiting and regurgitation
Time Frame: from the start of operation till 10 minutes postoperative
|
patients will be monitored to detect vomiting & regurgitation.
|
from the start of operation till 10 minutes postoperative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nesrine A. El-Refai, M.D, Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UTF-8
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medical Device Complication
-
University Hospital, Basel, SwitzerlandWithdrawnMedical Device ComplicationSwitzerland
-
Ministry of Health, RwandaCompletedMedical Device ComplicationRwanda
-
IWK Health CentreNot yet recruitingMedical Device | Aerosol Generating Procedure | Medical Device PerformanceCanada
-
Assistance Publique - Hôpitaux de ParisEvolucare Technologies; InES - Innovation Electronic SoftwareUnknown
-
Jun ChoiCompletedMedical DeviceUnited States
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMedical DeviceSwitzerland
-
University of MichiganTerminatedMedical Device | AngiographyUnited States
-
Novo Nordisk A/SCompletedHealthy Volunteers, Medical DeviceNetherlands
-
Interlinked ABParc Sanitari Sant Joan de Déu; Centro Hospitalar e Universitário de Coimbra...Recruiting
-
University of California, San DiegoCompletedMedical Device | Feasibility StudyUnited States
Clinical Trials on laryngeal mask insertion (Baska)
-
Kocaeli UniversityCompleted
-
Azienda Ospedaliero-Universitaria CareggiCompleted
-
Cairo UniversityCompleted
-
Seoul National University HospitalUnknown
-
Kocaeli Derince Education and Research HospitalCompleted
-
Asan Medical CenterCompletedUrinary Bladder Neoplasms | Laryngeal MasksKorea, Republic of
-
National Medical Center, SeoulCompletedAnesthesiaKorea, Republic of
-
Seoul National University HospitalCompletedGeneral Anesthesia | Elective SurgeryKorea, Republic of
-
Sohag UniversityNot yet recruiting